Who uses Illumina NovaSeq X?
NovaSeq X is a production-scale short-read sequencer, built for whole genomes and large studies run by genome centers and cores. It's made by Illumina. 3,525 bioRxiv and medRxiv preprints since April 2025 say they used NovaSeq X, 1,309 in the last 6 months. Updated daily (as of Nov 16)
Is NovaSeq X use still growing?
Yes: 1,309 preprints used NovaSeq X in Jun–Nov 2026, +47% vs the previous year as a share of all preprints. This is faster than short-read sequencers overall (+8%).
The last bar is the quarter so far. The % over each year compares it with the year before, as a share of all preprints.
How does NovaSeq X compare with other short-read sequencers?
NovaSeq X is the most-used of the four, with 44% of their uses in Jun–Nov 2026, up from 33% the year before.
Which institutions use NovaSeq X most?
The institutions using NovaSeq X most are Stanford University, University of California, San Francisco and University of California, Los Angeles.
Institutions
Stanford University92
University of California, San Francisco61
University of California, Los Angeles53
University of California, San Diego51
Johns Hopkins University48
Where the labs are
The lab's institution and country are the corresponding author's.
Rival platforms, head to head
Latest preprints using NovaSeq X
Who started using NovaSeq X recently?
263 institutions posted their first preprint using NovaSeq X since April 2025 in the last 6 months, including University of Padua, University of South Carolina and Massachusetts Institute of Technology.
University of PaduaJun 2, 2026
University of South CarolinaJul 22, 2026
Massachusetts Institute of TechnologyAug 4, 2026
RIKEN BioResource Research CenterJun 4, 2026
Barrow Neurological InstituteJun 25, 2026
University of KansasJul 24, 2026
University of BonnJul 24, 2026
University of TsukubaAug 10, 2026
Lieber Institute for Brain DevelopmentSep 26, 2026
University of GöttingenOct 14, 2026
An institution counts as new when its first preprint using NovaSeq X since April 2025 was posted in the last 6 months; the date is that first preprint.
What do labs use alongside NovaSeq X?
Preprints using NovaSeq X most often also use Chromium, NextSeq and Aurora. The count is preprints using both.
What is NovaSeq X used for?
Preprints using NovaSeq X are most often in genomics, microbiology and cancer biology.
Fields
Genomics 406Microbiology 395Cancer biology 323Neuroscience 316Immunology 297Molecular biology 245
Where the work was published
- Nature Communications39
- Proceedings of the National Academy of Sciences28
- eLife12
- Science Advances12
- Cell Reports11
- Nucleic Acids Research11
How we count which preprints use each platform
An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.